Results: 1-23 |
Results: 23

Authors: Levy, GA
Citation: Ga. Levy, Long-term immunosuppression and drug interactions, LIVER TRANS, 7(11), 2001, pp. S53-S59

Authors: Clark, DA Ding, JW Yu, G Levy, GA Gorczynski, RM
Citation: Da. Clark et al., Fg12 prothrombinase expression in mouse trophoblast and decidua triggers abortion but may be countered by OX-2, MOL HUM REP, 7(2), 2001, pp. 185-194

Authors: Levy, GA
Citation: Ga. Levy, C-2 monitoring strategy for optimising cyclosporin immunosuppression from the neoral((R) 1) formulation, BIODRUGS, 15(5), 2001, pp. 279-290

Authors: Knackstedt, M Ding, JW Arck, PC Hertwig, K Coulam, CB August, C Lea, R Dudenhausen, JW Gorczynski, RM Levy, GA Clark, DA
Citation: M. Knackstedt et al., Activation of the novel prothrombinase, fgl2, as a basis for the pregnancycomplications spontaneous abortion and pre-eclampsia, AM J REPROD, 46(3), 2001, pp. 196-210

Authors: Clark, DA Yu, G Levy, GA Gorczynski, RM
Citation: Da. Clark et al., Procoagulants in fetus rejection: the role of the OX-2 (CD200) tolerance signal, SEMIN IMMUN, 13(4), 2001, pp. 255-263

Authors: Yuwaraj, S Ding, JW Liu, MF Marsden, PA Levy, GA
Citation: S. Yuwaraj et al., Genomic characterization, localization, and functional expression of FGL2 the human gene encoding fibroleukin: A novel human procoagulant, GENOMICS, 71(3), 2001, pp. 330-338

Authors: Levy, GA
Citation: Ga. Levy, Charity begins at home: A message to the CAG membership, CAN J GASTR, 15(10), 2001, pp. 644-644

Authors: Malkan, G Humar, A Lilly, L Greig, PD Grant, D Wanless, IW Cameron, R Levy, GA Cattrall, MS
Citation: G. Malkan et al., Natural history of recurrent hepatitis C after liver transplantation, TRANSPLAN P, 33(1-2), 2001, pp. 1468-1468

Authors: Levy, GA Grant, D Paradis, K Campestrini, J Smith, T Kovarik, JM
Citation: Ga. Levy et al., Pharamacokinetics and tolerability of 40-0-[2-hydroxyethyl]rapamycin in denovo liver transplant recipients, TRANSPLANT, 71(1), 2001, pp. 160-163

Authors: Cattral, MS Lilly, LB Levy, GA
Citation: Ms. Cattral et al., Immunosuppression in liver transplantation, SEM LIV DIS, 20(4), 2000, pp. 523-531

Authors: Bigam, DL Pennington, JJ Carpentier, A Wanless, IR Hemming, AW Croxford, R Greig, PD Lilly, LB Heathcote, JE Levy, GA Cattral, MS
Citation: Dl. Bigam et al., Hepatitis C-related cirrhosis: A predictor of diabetes after liver transplantation, HEPATOLOGY, 32(1), 2000, pp. 87-90

Authors: Levy, GA
Citation: Ga. Levy, Neoral use in the liver transplant recipient, TRANSPLAN P, 32(3A), 2000, pp. 2S-9S

Authors: Belitsky, P Levy, GA Johnston, A
Citation: P. Belitsky et al., Neoral absorption profiling: An evolution in effectiveness, TRANSPLAN P, 32(3A), 2000, pp. 45S-52S

Authors: Malkan, G Cattral, MS Humar, A Al Asghar, H Greig, PD Hemming, AW Levy, GA Lilly, LB
Citation: G. Malkan et al., Lamivudine for hepatitis B in liver transplantation - A single-center experience, TRANSPLANT, 69(7), 2000, pp. 1403-1407

Authors: Levy, GA Liu, MF Ding, JW Yuwaraj, S Leibowitz, J Marsden, PA Ning, Q Kovalinka, A Phillips, MJ
Citation: Ga. Levy et al., Molecular and functional analysis of the human prothrombinase gene (HFGL2)and its role in viral hepatitis, AM J PATH, 156(4), 2000, pp. 1217-1225

Authors: Levy, GA
Citation: Ga. Levy, Neoral/cyclosporine-based immunosuppression, LIVER TR S, 5(4), 1999, pp. S37-S47

Authors: Clark, DA Ding, JW Chaouat, G Coulam, CB August, C Levy, GA
Citation: Da. Clark et al., The emerging role of immunoregulation of fibrinogen-related procoagulant fgl2 in the success or spontaneous abortion of early pregnancy in mice and humans, AM J REPROD, 42(1), 1999, pp. 37-43

Authors: Perampalam, S Wang, LQ Myers-Mason, N Yeow, JN Stanietsky, N Phillips, J Weitz, JI Ackerley, C Levy, GA Cole, EH
Citation: S. Perampalam et al., Identification of a unique glomerular factor X activator in murine lupus nephritis, J AM S NEPH, 10(11), 1999, pp. 2332-2341

Authors: Sim, KH Marinov, A Levy, GA
Citation: Kh. Sim et al., Xenotransplantation: A potential solution to the critical organ donor shortage, CAN J GASTR, 13(4), 1999, pp. 311-318

Authors: Levy, GA
Citation: Ga. Levy, Relationship of pharmacokinetics to clinical outcomes, TRANSPLAN P, 31(3), 1999, pp. 1654-1658

Authors: Hemming, AW Cattral, MS Greig, PD Lilly, LB Ashby, P Levy, GA
Citation: Aw. Hemming et al., Domino liver transplantation for familial amyloid polyneuropathy: Optimal use of a scarce resource, TRANSPLAN P, 31(1-2), 1999, pp. 515-515

Authors: Cattral, MS Hemming, AW Wanless, IR Al Ashgar, H Krajden, M Lilly, L Greig, PD Levy, GA
Citation: Ms. Cattral et al., Outcome of long-term ribavirin therapy for recurrent hepatitis C after liver transplantation, TRANSPLANT, 67(9), 1999, pp. 1277-1280

Authors: Clark, DA Chaouat, G Arck, PC Mittruecker, HW Levy, GA
Citation: Da. Clark et al., Cutting edge: Cytokine-dependent abortion in CBA x DBA/2 mice is mediated by the procoagulant fgl2 prothrombinase (vol 160, pg 545, 1998), J IMMUNOL, 162(5), 1999, pp. 3105-3105
Risultati: 1-23 |